4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione

4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione
Trade Name
Orphan Indication Progressive supranuclear palsy
USA Market Approval USA
USA Designation Date 2009-10-13 00:00:00
Sponsor NOSCIRA, S.A.;Avda. de la Industria, 52;Madrid